|
| Clinical Observation of Dengzhanhua Injection on Coronary Heart Disease |
| Hits 1380 Download times 1502 Received:March 06, 2002 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2002.03.11 |
| Key Words
Dengzhanhua Injection;Coronary heart disease;Blood rheology;ECG |
| Author Name | Affiliation | | Gao Sheng | Tianjin Nankai Hospital, Tianjin 300100, China | | Liu Qing | Tianjin Nankai Hospital, Tianjin 300100, China |
|
| Abstract
|
| Objective: To observe the clinical effect of Dengzhanhua Injection for treating coronary heart disease. Methods: Sixty patients were randomly and blindly assigned to receive routine oral dilational medicine for coronary artery plus Dengzhanhua Injection in treatment group (n=30) and dilational medicine alone in control group (n=30). Results: The total effective rates in treatment group and control group were 83.3% and 53.3% respectively with significant difference (P<0.05). Both of these two methods could markedly increase SOD and lower LPO in blood. Obvious difference was found between these two groups (P<0.05). For changes of ECG and blood rheology,the effective rates were 80%, 53.3% and 86.7%, 63.3% and the comparison of both parameters between two groups had significant difference (P<0.05). Conclusion: The therapeutic effect of combined use of Dengzhanhua Injection and routine administration of dilational medicine for coronary disease is better than that of the latter alone. |
|
